455(top 1%)
papers
18.7K(top 1%)
citations
76(top 1%)
h-index
119(top 1%)
g-index
519
all documents
19.7K
doc citations
2.6K
citing journals

Top Articles

#TitleJournalYearCitations
1Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseasesJournal of Experimental Medicine2008425
2Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceAnnals of the Rheumatic Diseases2014397
3Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathyArthritis and Rheumatism2002374
4How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomyNature Medicine2013341
5Meniscal allograft transplantation: long-term clinical results with radiological and magnetic resonance imaging correlationsKnee Surgery, Sports Traumatology, Arthroscopy2006331
6Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupAnnals of the Rheumatic Diseases2011330
7EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISITAnnals of the Rheumatic Diseases2009324
8Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot studyAnnals of the Rheumatic Diseases2000267
9Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestationsAnnals of the Rheumatic Diseases2004259
10Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trialLancet, The2018251
11A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritisNature Genetics2011250
12Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive modelAnnals of the Rheumatic Diseases2013230
13Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiativeAnnals of the Rheumatic Diseases2014222
14Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritisArthritis Research2005218
15Immunomodulatory effects of anti-tumor necrosis factor ? therapy on synovium in spondylarthropathy: Histologic findings in eight patients from an open-label pilot studyArthritis and Rheumatism2001210
16Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological studyAnnals of the Rheumatic Diseases2010193
17Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in miceBlood2012189
18Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA studyAnnals of the Rheumatic Diseases2016188
19Ankylosing spondylitis and bowel diseaseBest Practice and Research in Clinical Rheumatology2006187
20Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodiesArthritis and Rheumatism2001177
21Vaccinations in patients with immune-mediated inflammatory diseasesRheumatology2010176
22Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathyJournal of Pathology2002171
23Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritisArthritis and Rheumatism2005167
24Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgeryRheumatology2010165
25How to perform and interpret capillaroscopyBest Practice and Research in Clinical Rheumatology2013163
26Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?Annals of the Rheumatic Diseases2003159
27Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients reportKnee Surgery, Sports Traumatology, Arthroscopy2011154
28The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspectsJournal of Rheumatology1995150
29A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvementRespiratory Research2018149
30Human cartilage gp‐39+,CD16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritisArthritis and Rheumatism2000148
31European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesJournal of the European Academy of Dermatology and Venereology2017148
32Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot studyAnnals of the Rheumatic Diseases2012146
33Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosusAnnals of the Rheumatic Diseases2009143
34The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and jointJournal of Rheumatology1995136
35LTβR Signaling Induces Cytokine Expression and Up-Regulates Lymphangiogenic Factors in Lymph Node AnlagenJournal of Immunology2009135
36Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transitionJournal of Rheumatology1990134
37Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosusAnnals of the Rheumatic Diseases2004133
38Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre studyAnnals of the Rheumatic Diseases2010132
39Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathyArthritis Research2005127
40Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohortAnnals of the Rheumatic Diseases2014126
41A Plant-Derived Ligand Favoring Monomeric Glucocorticoid Receptor Conformation with Impaired Transactivation Potential Attenuates Collagen-Induced ArthritisJournal of Immunology2008125
42Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritisAnnals of the Rheumatic Diseases2010125
43Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society InternationalOsteoarthritis and Cartilage2006123
44How the microbiota shapes rheumatic diseasesNature Reviews Rheumatology2016122
45Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritisAnnals of the Rheumatic Diseases2005121
46An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseasesRheumatology2016121
47Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during SynovitidesJournal of Immunology2005118
48Targeting inflammation using selective glucocorticoid receptor modulatorsCurrent Opinion in Pharmacology2010115
49Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisAnnals of the Rheumatic Diseases2019115
50Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trialAnnals of the Rheumatic Diseases2018113